Helen Hobbs is an American molecular geneticist. Born May 5, 1952, in Boston. Educated at Stanford University. Awards include Pearl Meister Greengard Prize, Breakthrough Prize in Life Sciences and Heinrich Wieland Prize.
Facts
24 facts · 1 confirmed by two sources · 13 cited · 10 from one source
Where this comes from
Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.
What Wikidata says · copied November 19, 2026 · revision 2562703187
- Described as
- American molecular geneticist
- Other names
- Helen Haskell Hobbs
- Born
- May 5, 1952 · 1 reference
- Born in
- Boston
- Citizen of
- United States
- Occupation
- university teacher; biochemist; physician · 1 reference; molecular geneticist; researcher · 1 reference
- Worked for
- University of Texas System; Howard Hughes Medical Institute (2002–) · 2 references; University of Texas Southwestern Medical Center · 1 reference
- Education
- Stanford University
- Member of
- American Academy of Arts and Sciences (2006–) · 1 reference; National Academy of Sciences (2007–) · 1 reference
- Awards
- Pearl Meister Greengard Prize (2015) · 1 reference; Breakthrough Prize in Life Sciences (2016) · 1 reference; Heinrich Wieland Prize (2005) · 1 reference; Jay and Jeanie Schottenstein prize in cardiovascular science (2017) · 1 reference; Robert J. and Claire Pasarow Foundation Award for Distinguished Contributions to Cardiovascular Research (2013) · 1 reference; honorary doctor of the University of Ferrara (2003); Fellow of the American Association for the Advancement of Science (2015) · 1 reference; George M. Kober Lectureship (2018) · 1 reference; Howard Taylor Ricketts Prize (2022) · 1 reference; Scientific Grand Prize of the Lefoulon-Delalande Fondation (2018) · 1 reference
- Wikipedias with a page
- 10
Wikidata item Q21433424 (wikidata.org/wiki/Q21433424), public domain (CC0). Copied November 19, 2026.
What Wikipedia says · copied November 19, 2026 · revision 1381365639
Helen Haskell Hobbs (born May 5, 1952 in Boston, Massachusetts) is an American medical researcher who is professor at the University of Texas Southwestern Medical Center, and a Howard Hughes Medical Institute Investigator, who won a 2016 Breakthrough Prize in Life Sciences and the 2018 Harrington Prize for Innovation in Medicine. Hobbs specializes in the dysregulation of lipid metabolism and how it affects human diseases. She and Jonathan C. Cohen found that people with hypomorphic PCSK9 mutations had lower LDL-cholesterol levels and were almost immune to heart disease. This finding led to the development of a new class of cholesterol-lowering drugs that mimic the effects of the PCSK9 mutations. She and Cohen also identified the first genetic risk factor for fatty liver disease, a burgeoning health problem that can lead to cirrhosis and liver cancer. Their laboratory has shown that mutation in PNPLA3 causes accumulation of PNPLA3 on lipid droplets, which compromises the mobilization of triglycerides from liver cells. She sits on the Board of Directors at Pfizer.
- Born, in its opening lines
- May 5, 1952
From the Wikipedia article “Helen Hobbs” (en.wikipedia.org/wiki/Helen_Hobbs), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied November 19, 2026; not changed.
Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.